and treatment of nausea and vomiting in the setting of cesarean delivery. Currently, there is a dearth of effective therapies in the setting of established PONV. Ondansetron has limited success as a Brescue[ antiemetic when previously given as a prophylactic agent. In this circumstance, there is a potential role for the combined use of pharmacologic and nonpharmacologic treatments. Because ondansetron and acupuncture operate via different pathways, their antiemetic effects may be additive, or even synergistic. Ondansetron, a selective 5-HT 3 antagonist, blocks the proemetic influence of serotonin on peripheral vagal nerve terminals and on the central chemoreceptor trigger zone. Although the precise mechanism is not clearly defined, it has been suggested that acupuncture modulates endogenous neurotransmitters, influences nausea centers, and inhibits relaxation of the lower esophageal sphincter. Although this study focused on the role of acupuncture in the prevention of PONV, further studies are needed to explore the potential of this therapy as a combination technique, especially in the setting of established nausea and vomiting.A lthough extended-release epidural morphine (EREM) provides superior and prolonged analgesia after cesarean delivery compared with conventional epidural morphine, studies have indicated that an interaction between epidural lidocaine and EREM may negate the sustained-release effect and may result in higher peak serum morphine concentrations. No previous study has determined the pharmacokinetic and drug effects of a large volume of 2% lidocaine before EREM administration. This single-center, randomized, blinded study was undertaken to compare the pharmacokinetic profiles of EREM alone or after a large dose of 2% lidocaine.Thirty patients with a singleton pregnancy having a cesarean delivery during regional anesthesia were enrolled. Patients in group E (epidural) received an epidural top-up anesthetic of 2% lidocaine with epinephrine 1:200,000 and sodium bicarbonate. The lidocaine solution was given in 5-mL increments every 2.5 minutes until a T6 sensory level was reached. They also received fentanyl through the epidural catheter after 10 mL of the lidocaine solution had been administered. Group SE (spinal/ epidural) received a combined spinal-epidural anesthetic of 12 mg hyperbaric bupivacaine 0.75% with 20 Kg fentanyl, given intrathecally; no local anesthetic was given through the epidural catheter. At 1 hour after the intrathecal dose in group SE or after the initial lidocaine administration in group E, all patients received EREM 8 mg (DepoDur) through the epidural catheter. In group E, if patients had intraoperative pain during the delivery, additional epidural 2% lidocaine was administered. If additional doses of epidural lidocaine were required, EREM was not given for at least an additional 30 minutes after a bolus of 2.5 to 7.5 mL or an additional 60 minutes after a bolus of 7.5 to 15 mL. The maximum total lidocaine dose permitted was 35 mL. If a patient in group SE had intraoperative...